The absence of ATGL induces the development of lung tumors in animal models and low levels of ATGL are associated with poor survival in patients with ovarian cancer, NSCLC, breast cancer, and stomach cancer [72]. Here, PNPLA2 is linked to non-small cell lung carcinoma.